PEDRO LOPEZ, MD
Pulmonary Disease Physician in TUSCALOOSA, Alabama. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
PEDRO LOPEZ, MD filed 1,360 Medicare Part D claims in 2023 as a Pulmonary Disease Physician in TUSCALOOSA, Alabama, prescribing 20% generic.
- 1K
- Part D claims, 2023
- 20%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
PEDRO LOPEZ, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
1,360 Top 21% higher than 79% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
PEDRO LOPEZ, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about PEDRO LOPEZ, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Alabama
How Pulmonary Disease Physician compares to other specialties among Alabama providers
Pulmonary Disease Physician share within Alabama
Pulmonary Disease Physician is one of the more visible NUCC categories in Alabama
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Pulmonary Disease Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Pulmonary Disease Physician ABMS/AOA estimate
Est. board-certified rate (Pulmonary Disease Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Pulmonary Disease Physician US NPIs
Specialty board-certified rate — Pulmonary Disease Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
PEDRO LOPEZ, MD appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding MD credentials at 701 UNIVERSITY BLVD E, TUSCALOOSA, AL, 35401, with a listed phone of (205) 345-2255. NPI 1295796472 was issued on 03/29/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LOPEZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,360 prescription claims written by this provider, covering 237 Medicare beneficiaries and totaling roughly $625K in drug spend, split 80% brand-name and 20% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1295796472 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 03/29/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm PEDRO LOPEZ, MD's current license status, disciplinary history, and board certifications with the Alabama Board of Medical Examiners in Alabama before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where PEDRO LOPEZ, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for PEDRO LOPEZ, MD. Source: openpaymentsdata.cms.gov.
Total received
$2.8K
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
80% brand-name claims vs 20% generic, on 1,360 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,625
- Total Day Supply
- 44,460
- Brand vs Generic
- 80% brand / 20% generic
- Brand Drug Cost
- $612K
- Generic Drug Cost
- $13K
- Antibiotic Claims
- 20
Patient Demographics
- Average Patient Age
- 71.6 years
- Avg HCC Risk Score
- 1.67
- Gender Split
- 55% female / 45% male
- Age Distribution
- <65: 41, 65-74: 113, 75-84: 64, 85+: 19
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What PEDRO LOPEZ, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Albuterol Sulfate …
Albuterol Sulfate Hfa
389 claims
- Trelegy Ellipta
Trelegy Ellipta
189 claims
- Breo Ellipta 147
Breo Ellipta
147 claims
- Anoro Ellipta 116
Anoro Ellipta
116 claims
- Arnuity Ellipta 109
Arnuity Ellipta
109 claims
- Stiolto Respimat 104
Stiolto Respimat
104 claims
- Ventolin Hfa 53
Ventolin Hfa
53 claims
- Symbicort 36
Symbicort
36 claims
| Drug | Claims |
|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 389 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 189 |
| Breo Ellipta Fluticasone/Vilanterol | 147 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 116 |
| Arnuity Ellipta Fluticasone Furoate | 109 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 104 |
| Ventolin Hfa Albuterol Sulfate | 53 |
| Symbicort Budesonide/Formoterol Fumarate | 36 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 33 |
| Spiriva Respimat Tiotropium Bromide | 23 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How PEDRO LOPEZ, MD fits within the Pulmonary Disease Physician landscape nationally.
PEDRO LOPEZ, MD's 1,360 claims are below the specialty average of 1,457.
Nearby Pulmonary Disease Physician Providers in Alabama
Other clinicians with the same primary specialty enrolled in Alabama, drawn from the same CMS NPPES roster as LOPEZ.
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Alabama
Frequently Asked Questions
What is PEDRO LOPEZ, MD's specialty? ▼
How much does PEDRO LOPEZ, MD prescribe under Medicare Part D? ▼
Where is PEDRO LOPEZ, MD located? ▼
What is PEDRO LOPEZ, MD's NPI number? ▼
Does PEDRO LOPEZ, MD prescribe more brand-name or generic drugs? ▼
How many Pulmonary Disease Physician providers are there in the US? ▼
What drugs does PEDRO LOPEZ, MD prescribe most often? ▼
Does PEDRO LOPEZ, MD accept Medicare? ▼
How can I verify PEDRO LOPEZ, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology